Latest Publications
Learn about Improved Pharma’s approach to polymorph and salt screening
Polymorph screens and salt screens are important components for drug development. The goal of polymorph screening is to try to find all possible crystal forms by small-scale crystallization and to select a stable form thatRead more
Improved Pharma Introduces Synchrotron-Based Fast to IND (S-fIND) Development Services
Accelerated development is a complex and difficult task. S-fIND (Synchrotron-based fast to IND) is a strategy to speed development of the most difficult cases using powerful X-ray methods only available at a Synchrotron X-ray source. S-fINDRead more
Improved Pharma Announces New Raman Microscopy Abilities and Collaboration with Chemical Microscopy, LLC
WEST LAFAYETTE, IND. (PRWEB) JUNE 02, 2020 In response to growing demands for services, Improved Pharma, LLC is pleased to announce a collaboration with Dr. Dale K. Purcell of Chemical Microscopy, LLC to provide services related to microscopyRead more
Are Polymorphs Obvious?
Not according to the United States Court of Appeals, citing Improved Pharma’s CSO Steve Byrn’s early paper on polymorph screening. The United States Court of Appeals for the Federal Circuit is known as theRead more
Improved Pharma announces expansion of services to include infrared microspectroscopy and hot stage optical microscopy
WEST LAFAYETTE, IN (PRWEB) MAY 06, 2020 Improved Pharma has added new capabilities to their existing microscopy services. Now in addition to stereomicroscopy and polarized light microscopy, Improved Pharma can provide analysis via infrared microspectroscopyRead more
Solving Difficult Polymorph Mixture Problems Using Synchrotron X-Ray Diffraction
A recent paper by Testa et al., Int. J. Pharm., 556 (2019) 125, investigated the mixture analysis of Olanzapine, which crystallizes in more than 60 solid forms, using synchrotron X-ray diffraction. They suggested that synchrotronRead more